Paul Hastings Advised J.P. Morgan in Connection with Leap Therapeutics’ PIPE Financing
Paul Hastings LLP advised J.P. Morgan Securities LLC as the exclusive placement agent in connection with Leap Therapeutics, Inc.’s private placement (PIPE). Leap Therapeutics, Inc., (Nasdaq: LPTX) is a biotechnology company focused on developing targeted and immune-oncology therapeutics.
Partner and Co-head of Equity Capital Markets and Co-chair of the Corporate Life Sciences Group Seo Salimi and Securities and Capital Markets partner Will Magioncalda led the Paul Hastings team, which also included associate Lauren Zhang.
More details on the transaction can be found here.
With widely recognized elite teams across 18 core practices, Paul Hastings is a premier law firm with a culture of excellence focused on providing intellectual capital and superior execution globally to the world's leading investment banks, asset managers and corporations.